Epstein-Barr virus (EBV) DNA was detected in polyclonal T cells that proliferated transiently in a 21 -year-old male (referred t o as H.J.) who underwent an apparently benign lymphocytosis (white blood cells, 31.2 x 10s/pL; lymphocyte. 79%) with fever, tonsillar swelling, lymphadenopathy, and hepatosplenomegaly. The symptoms and signs subsided mostly within a month of hospitalization. The major population of the lymphocytes at admission was positive for CD3, CD8 (4/8 ratio, 0.16). WT31, and DR antigen. Eight percent of the leukocytes were too blastoid t o be classified as atypical lymphocytes of infectious mononucleosis (IM). The blastoid lymphocytes and the duration and degree of the lymphocytosis and hypergammaglobulinemia appeared inconsistent with IM, whereas the EBV serology indicated either EBV primary infection or a secondary alteration of normal seropositive EBV immunity.The genomic analysis of T-cell receptor @ chain in the peripheral
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PSTEIN-BARR VIRUS (EBV) causes infectious mono-
E nucleosis (IM) in primary infection,' and the EBV genome is found in Burkitt's lymphoma,2 nasopharyngeal carcinoma,3 and lymphomas supervening various immunodeficient state^.^ The target cells of EBV infection have been considered to be exclusively B lymphocytes,2 oropharyngeal e~ithelial,~ and salivary gland ductal cells.' However, recently EBV DNA has also been detected in non-B hematopoietic cells such as the CD4+ T-lymphoma cells6 and the peripheral blood proliferative CD4+ T cells obtained from children in whom EBV serology was reactivation It seems that EBV can infect hematopoietic cells other than B lymphocytes, and contribute to diseases that have not been regarded as related to EBV.
While performing EBV DNA Southern blot study with the peripheral blood lymphocytes obtained from acute IM patients, in which EBV genome was not detected, it was unexpectedly detected in a fraction of the CD3+8+ lymphocytes obtained from a young male patient with acute benign lymphocytosis. throat that had started 10 days previously. He had bilateral tonsillar swelling with white coat, cervical lymphadenopathy, hepatosplenomegaly, elevated white blood cell (WBC) count with lymphocytosis (WBC 31.2 x 103/pL, lymphocyte 79%) and abnormal liver function tests. Because of the blastoid lymphocytes (18%), he was transferred to the Second Department of Internal Medicine, Kobe University Hospital on July 21. Aside from the above-mentioned physical signs, axillar and groin lymphadenopathy were noted. The WBC was 23.2 x 1O3/pL(band, 7%; seg, 11%; ly, 82%; eos, 0%; bas, 0%). Eight percent of the leukocytes were large blastoid lymphocytes, having a three-to fourfold diameter of erythrocytes, broad variably basophilic cytoplasm, occasionally large granules, and a lobulated or indented nucleus (Fig 1) . Ten percent of the leukocytes could be classified as the atypical lymphocytes in IM. The former, latter, and normal lymphocytes constituted a continuous morphologic spectrum. The sternal marrow aspiration (NCC 72.1 x IO3/ pL) showed a normal cell component except for the slightly elevated lymphocyte count (37%), including 2% abnormal lymphocytes similar to those observed in the peripheral blood. The total bilirubin was 0.9 mg/dL, GOT 258 (WNL, 9-36); GPT 386 (WNL, 7- 
'
The serology of EBV, which was performed according to Henle and Henle,' is shown in Table 1 , indicating the absence of significant anti-early antigen (EA) elevation and a retarded appearance of anti-EBV-associated nuclear antigen (EBNA). The cytomegalovirus (CMV) serology (complement fixation) was x 3 2 on July 25, and x 2 on August 11. The antibodies against human T-lymphotro-
pic virus I (HTLV-I) and human immunodeficiency virus (HIV),
which were tested by enzyme-immunoassay (Eitest-ATL, Eisai. Tokyo, Japan) and gelatin-particle agglutination (Serodia-HIV, Fujirebio, Tokyo, Japan), respectively, were undetectable. The Paul-Bunnell titer was x 112 on July 25 and August 19. After a week of hospitalization, the clinical and laboratory abnormalities began to return to normal. The abnormal morphology of the lymphocytes became less and less conspicuous. A left cervical lymph node (1.0 cm in diameter) was biopsied on July 28. The histologic diagnosis was lymphadenitis.
The patient was discharged on August 21, 1988, when the serum y-globulin fraction was 28.6%. and IgG 2,975 mg/dL. Thereafter he was consistently symptom-free. Phenotypic analysis of the periph- was below 0.25. They had typical IM symptoms and signs such as fever, sore throat due to tonsillar swelling followed by systemic lymphadenopathy, hepatosplenomegaly, and lymphocytosis. The serology showed positive anti-VCA, transient elevation of anti-EA, and absence of anti-EBNA. After 2 to 3 months, anti-EBNA became detectable. Cell surface antigen analysis. The mononuclear cells were separated from the peripheral blood or the bone marrow aspirate by Ficoll-Hypaque discontinuous density gradient centrifugation and from the lymph node by mincing. The cells were stained by a direct or indirect cell surface immunofluorescence test, using a total of 19 monoclonal antibodies (MoAbs) ( Table 2) : NUT-ER (CD2).
(CD8). NUN1 (CDIO), MCS2 (CD13), and NUI-A (HLA-DR) were purchased from Nichirei (Tokyo, Japan); Leu9 (CD7). Leu1 1 (CD16). Leu12 (CD19), Leu16 (CD20), CR2 (CD21). and Leu7 were from Becton-Dickinson (Mountainview, CA); Mol (CDI 1) and TI0 (CD38) were from Coulter (Hialeah, FL); and Clonab DQ (HLA-DQ) was from Biotest (Dreieich, West Germany). TAC (CD25)'" was a gift from Dr T. Uchiyama (First Department of Internal Medicine, Kyoto University, Japan); WT3 1 I ' was from Dr W. Tax (Department of Medicine, University of Nijmegen, The Netherlands); and TCRGl l 2 from Dr M.B. Brenner (Dana-Farber Cancer Institute, Boston, MA). FITC-conjugated goat anti-mouse IgG and IgM (GAM-FITC, Coulter) were used for indirect immunofluorescence. To block Fc receptors, heat-aggregated (SOOC, 30 minutes) human IgG (SOmg/mL)(Venilon, Fujisawa, Osaka, Japan) was added 10 minutes beforeeach incubation, except for CD16. Incubation was for 30 minutes at 4OC. The stained cells were assayed with an Epics-C flow cytometer (Coulter).
Southern blor analysis. High molecular weight DNA was extracted from the frozen peletted mononuclear cells as described." The DNA was digested with BamHI (Takara. Kyoto, Japan), EcoRI (Takara), or HindIII (Takara). The restriction fragments were size-fractionated on 0.7% agarose gel and transferred to Gene Screen Plus nylon membranes (New England Nuclear, Boston, MA) as des~ribed.".'~ The probes were labeled with 32P by the random priming method (Amersham, Buckinghamshire, England). After hybridizing with the labeled probe, the nylon membranes were washed at the appropriate stringency and autoradiographed.
For T-cell receptor B chain gene analysis, the BamHI, EcoRI, or HindIII digests were hybridized with CB1 probe," and the HindIII- 
NUT3 (CD3), NUT-H/I (CD4). NUT-PAN (CDS), NUT-S/C

RESULTS
The results of cell surface antigen analysis are shown in Table 2 . The major proliferating population in the H.J. peripheral blood a t admission was positive for CD2, CD3, CD7, CD8, and WT3 1 antigen. The 4/8 ratio was 0.16. The antigens associated with activation or proliferation, such as CD38 and HLA-DR, were positive. The B-cell (CD19, CD20) or myeloid (CDI 1, CD13) antigens were negative. In the lymph node cells, the 4/8 ratio was 1. I, indicating that the lymph node retained a significant size of CD4' population. The follow-up studies showed a very gradual normalization of the peripheral blood T-cell subset. A notable finding was the increaseof CD16' and Leu7' cells on February 27, 1989. However, on June 2, 1989 it was less marked.
Gene analysis of T-cell receptor (TCR) /3 chain and EBV. Gene rearrangement analysis of the TCR /3 chain by hybridizing the BumHI-or EcoRI-digested DNA of the H.J. (July 22, 1988) cells with the C/31 probe is shown in Fig 2. A marked diminution of the density of the germ-line bands, the 11-or 4-kb band, and the 23-kb band in the EcoRI and BamHI digests, respectively, was observed in the H.J. DNA (July 22, 1988) compared with those of placental DNA. N o clonal rearranged band was detectable. The hybridization with Hind-I11 digests did not show a monoclonal band either (data not shown). These results indicate that the CD3'8' cells were polyclonal in terms of TCR / 3 chain gene structure.
When the DNA extracted from the PBMC of the six patients with acute IM was tested for EBV by genomic study, the H.J. (July 22, 1988 ) DNA was fortuitously included. When hybridized with the BamHI W probe, a 3.4-kb band was observed in the BamHI-digested H.J. (July 22, 1988) and Raji cell DNA (Fig 3) (Fig 4) .
DISCUSSION
IM did not seem a likely clinical diagnosis in H.J. because of the large blastoid cells, and the duration and degree of hypergammaglobulinemia and lymphocytosis, although the basic outline of H.J.'s illness, a self-limited CD3+8+ lymphocytosis with tonsillitis and lymphadenopathy, was IM-like. As to the serology, the absence of anti-EA elevation in the acute phase did not necessarily exclude primary EBV infection, since anti-EA remains at an undetectable level in some typical IM patientsz2 The duration necessary for the seroconversion of H.J. anti-EBNA, at least 7 months, was unusually long compared with 2 to 3 months in the six typical IM patients, indicating either EBV primary infection or a secondary profound effect on normal seropositive EBV immune status.
The detection of EBV DNA in the H.J. ( 
